Fucoxanthin anti-tumor effects on the proliferation, angiogenesis, apoptosis, and migration of triple-negative breast cancer cells.

被引:0
|
作者
Ahmed, Shade' [1 ]
Mendonca, Patricia [1 ]
Messeha, Samia [1 ]
Badisa, Ramesh [1 ]
Soliman, Karam F. [1 ]
机构
[1] Florida A&M Univ, Tallahassee, FL 32307 USA
关键词
D O I
10.1158/1538-7755.DISP22-C021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
C021
引用
收藏
页码:236 / 237
页数:2
相关论文
共 50 条
  • [21] Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
    Yan Zhou
    Shuchen Lin
    Kuo-Fu Tseng
    Kun Han
    Yaling Wang
    Zhi-hua Gan
    Da-liu Min
    Hai-yan Hu
    BMC Cancer, 16
  • [22] Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
    Zhou, Yan
    Lin, Shuchen
    Tseng, Kuo-Fu
    Han, Kun
    Wang, Yaling
    Gan, Zhi-hua
    Min, Da-liu
    Hu, Hai-yan
    BMC CANCER, 2016, 16
  • [23] Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
    Pitts, Todd M.
    Simmons, Dennis M.
    Bagby, Stacey M.
    Hartman, Sarah J.
    Yacob, Betelehem W.
    Gittleman, Brian
    Tentler, John J.
    Cittelly, Diana
    Ormond, D. Ryan
    Messersmith, Wells A.
    Eckhardt, S. Gail
    Diamond, Jennifer R.
    CANCERS, 2020, 12 (03)
  • [24] EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer
    Li, Zishuo
    Liu, Qiao
    Cai, Yuhao
    Ye, Na
    He, Zinan
    Yao, Yuying
    Ding, Yi
    Wang, Pingyuan
    Qi, Cuiling
    Zheng, Lingyun
    Wang, Lijing
    Zhou, Jia
    Zhang, Qian -Qian
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (04):
  • [25] Anti-tumor activity of BET inhibitors in androgen-receptor- expressing triple-negative breast cancer
    Park, In Hae
    Yang, Han Na
    Jeon, Su Yeon
    Hwang, Jung-Ah
    Kim, Min Kyeong
    Kong, Sun-Young
    Shim, Sung Hoon
    Lee, Keun Seok
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [26] Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer Therapy
    Nam, Sung Ouk
    Yotsumoto, Fusanori
    Miyata, Kohei
    Fukagawa, Satoshi
    Odawara, Takashi
    Manabe, Sadao
    Ishikawa, Toyokazu
    Kuroki, Masahide
    Yasunaga, ShiN'Ichiro
    Miyamoto, Shingo
    ANTICANCER RESEARCH, 2016, 36 (07) : 3651 - 3657
  • [27] Effects of Sulforaphane in the Tumor Microenvironment of Triple-Negative Breast Cancer
    Slattery, Ed
    Cline, Troy
    Housley, Lauren
    FASEB JOURNAL, 2017, 31
  • [28] Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer
    Wu, Lisha
    Bai, Shoumin
    Huang, Jing
    Cui, Guohui
    Li, Qingjian
    Wang, Jingshu
    Du, Xin
    Fu, Wenkui
    Li, Chuping
    Wei, Wei
    Lin, Huan
    Luo, Man-Li
    CANCERS, 2023, 15 (12)
  • [29] Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer
    In Hae Park
    Han Na Yang
    Su Yeon Jeon
    Jung-Ah Hwang
    Min Kyeong Kim
    Sun-Young Kong
    Sung Hoon Shim
    Keun Seok Lee
    Scientific Reports, 9
  • [30] Birinapant enhances gemcitabine's anti-tumor efficacy in triple-negative breast cancer by inducing intrinsic pathway-dependent apoptosis
    Xie, Xuemei
    Lee, Jangsoon
    Pearson, Troy
    Lu, Alexander Y.
    Tripathy, Debu
    Devi, Gayathri R.
    Bartholomeusz, Chandra
    Ueno, Naoto T.
    CANCER RESEARCH, 2020, 80 (16)